<DOC>
	<DOCNO>NCT00343902</DOCNO>
	<brief_summary>To determine effect hawthorn extract 450 mg bid vs. placebo , addition standard medical therapy ambulatory patient NYHA class II IV chronic heart failure submaximal exercise measure 6-minute walk test</brief_summary>
	<brief_title>Hawthorn Extract Randomized Blinded Chronic Heart Failure ( HERB CHF ) Trial</brief_title>
	<detailed_description>See Brief Summary</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Ambulatory individual 18 year old diagnose CHF ( NYHA functional class IIIV ) &gt; 3 month Left ventricular ejection fraction ( LVEF ) ≤ 40 percent Receiving indicate standard therapy ( contraindicate intolerant &gt; 3 month ) define diuretic , ACEinhibitor angiotensin receptor blocker ( ARB ) betablocke Patients NYHA class III IV symptom also require receive spironolactone . Doses drug stable ≥ 3 month , except diuretic , ≥ 1 month stability require . Hemodynamically severe uncorrected primary valvular disease Active myocarditis Hypertrophic cardiomyopathy Restrictive cardiomyopathy Myocardial infarction , stroke , unstable angina , coronary artery bypass graft surgery , valvular surgery , angioplasty &lt; 3 month randomization Symptomatic sustain ventricular tachycardia control antiarrhythmic drug implantable cardioverterdefibrillator Any condition heart failure would expect limit exercise ( e.g. , angina , peripheral vascular disease , pulmonary disease , arthritis , orthopedic problem severe enough limit exercise ) Nursing mother , pregnant woman plan pregnancy study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hawthorn</keyword>
	<keyword>Crataegus</keyword>
	<keyword>Herbs</keyword>
</DOC>